@@@@@Shire Completes Acquisition of NPS Pharma Dublin, Ireland – February 21, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and the subsequent acquisition of NPS Pharma.
too bad---smile all the way to the bank and counterbalance with any losses you may have in your portfolio Beats the heck out of a loss so whiners are not welcome here.
Been on YMB for 16 years and I think this my 2 nd post. LOL. Have owned NPSP for a long time and sold yesterday. Made a bundle selling covered calls and hit the home run yesterday. I think they sold too low, but I'll take the nice profit ($39/share) and run. I wish all longs the best of luck in their next stock purchase.
blind to the world... but the brokers will take commissions on your trades anyway.
The transaction will happen before the end of the first quarter. Go to the investor relations page of NPS. A good lesson for everyone is to always look at the investor relations pages of all companies, for information and activities.
Yeah, I hedged it by selling 7/12 of my shares in my IRA accounts first and waited on the balance in my taxable account. It's a lot of $ to re-invest, so I felt that it was best to leave for the FDA decision (educated risk) If not approved, I felt it would only be a temporary setback.. I am also planning to use some of my taxable shares for charitable contributions. Saves on taxes.
Correct. Accelerated expiry applies. ITM (In The Money) strikes will receive cash equal to the difference between the strike price and $46. OTM will expire worthless. Time premium across all expiry dates goes out the window... Wall Street thanks everyone for playing and have a nice day.
Hi JM77, I sold because I didn't want to wait several months for .04 cents. I can invest my profits in other stocks I have done my Due Diligence (DD) on and get a better return. In my case I bought more MNKD at $5.45/share and today it's at $7.00. So in 3 weeks I made $1.55/share over the .04 cents. If you got an offer for $47 I'd take it and run. Best of luck to you!
NVIV's first Spinal Cord Injury patient ( out of 5 allowed by FDA in first human trial) has really progressed very ,very well. You can see a video of Jordan Fallis now able to crawl on Go Fund Me site. If site wants you to donate to watch video ( not sure as I am a donor and they send me updates) you should be able to You Tube Jordan Fallis rehab I believe. NVIV now has patient # 2 enrolled as well. Should be able to take patient #3 in another approx 30 days. NVIV is an OTC . NVIV did do an offering yesterday and has plenty of money now to see them through next Pivotal Trail which will be much larger.
NVIV only has to prove safety for this trail. No problem ...... Their " scaffold is made of the same material that has been used for sutures etc for many years. My bet is they will up list by mid 2015.
Cheers all . Good luck.
TD Ameritrade waives the fee for APEX clients. If you are a good client with a moderate number of trades, balance and maybe some margin interest you could probably get the same consideration from your broker.
I finally got cashed-out of the last of my shares on Wed. (3/4) from my Scottrade account. Assume this MB will be shutdown shortly. GL
Just be happy SHPG bought out NPSP. I can only imagine how this type of filing would have hit the stock price if NPSP was still on their own.
@@@@@Kyle Bass is expanding his campaign against pharmaceutical companies. Shire Plc is the newest target of the hedge fund manager’s strategy to challenge drug patents, according to filings Wednesday with the U.S. Patent and Trademark Office. Bass is challenging patents on Lialda and Gattex, according to the filings, which together would have made up 12 percent of Shire’s revenue in 2014.He’s now challenging Shire’s Gattex, a treatment for short bowel syndrome that the company got through its $5.2 billion purchase of NPS Pharmaceuticals Inc., which closed in February. Lialda, a colitis medicine, generated $633.8 million in sales last year for the Dublin-based drugmaker.
I paid $20 in my Scottrade account for the corp. reorg. fee. Same thing happened for QCOR and AVNR buy-outs. I find it is a small fee and it paid to wait, rather than take the hair-cut in PPS to sell before the tender offer was completed. I did sell most of my shares before the tender to hedge against the risk of the deal falling apart. FYI - I use a cash only account - no margin. It keeps my broker from lending my shares to the shorts, who are working against my best interests. GL